ANASTROZOLE

Clinical Indication

Off label chemoprevention to reduce incidence of breast cancer.

Comments

Use in line with NICE CG 164

Date of classification

June 2018

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.